Sign up to save your podcasts
Or
Share Celebrating Episode 100 with the Greatest Hits from Derms and Conditions 2024
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Celebrating Episode 100 with the Greatest Hits from Derms and Conditions 2024
In this milestone 100th episode of Derms and Conditions, host James Del Rosso, DO, takes listeners on a year-in-review journey through some of the greatest highlights from 2024. This special solo episode reflects on standout conversations with leading dermatologists and previews exciting plans for 2025.
Dr Del Rosso revisits key insights from some of the most impactful episodes on this 100th Episode of Derms and Conditions Podcasts:
Episode 91 with Dr Joel Gelfand explored psoriasis comorbidities and the importance of connecting with patients on both physical and mental health. Dr Gelfand emphasized the need for dermatologists to assess cardiovascular risks and encourage patients to engage with their broader medical team.
Episode 89 with Dr Jessica Kaffenberger took a deep dive into hidradenitis suppurativa, including strategies to address disease chronicity, tackle psychosocial aspects, weight and smoking challenges tactfully, initiating biologic agents early to halt disease progression before permanent sequelae markedly increase and specific tips for using intralesional corticosteroids and infliximab infusion for severe cases.
Episode 96 with Dr David Cotter explored the art and science of patch testing, especially for patients with atopic dermatitis who may have concurrent allergic contact dermatitis. Dr Cotter shared practical advice on tailoring patch testing and considerations regarding ongoing medications used to treat atopic dermatitis.
Episode 90 with Dr Jason Hawkes took a closer look at TYK2 inhibition with deucravacitinib, highlighting its novel allosteric mechanism, its more selective pathway inhibition, and 4-year safety and efficacy data.
Episode 97 with Dr Tina Bhutani provided insights on newer nonsteroidal topicals like roflumilast and tapinarof, including tips for integrating these agents with corticosteroids and using them under occlusion for thicker lesions.
With so many exceptional episodes in 2024 and exciting plans ahead, listeners can look forward to even more cutting-edge insights in 2025. Don’t miss any of these conversations—catch up anytime at dermsquared.com/podcasts/derms-and-conditions
View all episodes
By Dermsquared
4.9
5151 ratings
In this milestone 100th episode of Derms and Conditions, host James Del Rosso, DO, takes listeners on a year-in-review journey through some of the greatest highlights from 2024. This special solo episode reflects on standout conversations with leading dermatologists and previews exciting plans for 2025.
Dr Del Rosso revisits key insights from some of the most impactful episodes on this 100th Episode of Derms and Conditions Podcasts:
Episode 91 with Dr Joel Gelfand explored psoriasis comorbidities and the importance of connecting with patients on both physical and mental health. Dr Gelfand emphasized the need for dermatologists to assess cardiovascular risks and encourage patients to engage with their broader medical team.
Episode 89 with Dr Jessica Kaffenberger took a deep dive into hidradenitis suppurativa, including strategies to address disease chronicity, tackle psychosocial aspects, weight and smoking challenges tactfully, initiating biologic agents early to halt disease progression before permanent sequelae markedly increase and specific tips for using intralesional corticosteroids and infliximab infusion for severe cases.
Episode 96 with Dr David Cotter explored the art and science of patch testing, especially for patients with atopic dermatitis who may have concurrent allergic contact dermatitis. Dr Cotter shared practical advice on tailoring patch testing and considerations regarding ongoing medications used to treat atopic dermatitis.
Episode 90 with Dr Jason Hawkes took a closer look at TYK2 inhibition with deucravacitinib, highlighting its novel allosteric mechanism, its more selective pathway inhibition, and 4-year safety and efficacy data.
Episode 97 with Dr Tina Bhutani provided insights on newer nonsteroidal topicals like roflumilast and tapinarof, including tips for integrating these agents with corticosteroids and using them under occlusion for thicker lesions.
With so many exceptional episodes in 2024 and exciting plans ahead, listeners can look forward to even more cutting-edge insights in 2025. Don’t miss any of these conversations—catch up anytime at dermsquared.com/podcasts/derms-and-conditions
More shows like Derms and Conditions
View all
JDD Podcast: Ask the Investigator
67 Listeners
White Coat Investor Podcast
2,440 Listeners
The Doctor Youn Show
1,135 Listeners
JAMA Dermatology Author Interviews
16 Listeners
Dermalogues with Dr. Kerri Purdy
14 Listeners
Learn Skin with Dr. Raja and Dr. Hadar
36 Listeners
The Grenz Zone
382 Listeners
Dermasphere - The Dermatology Podcast
143 Listeners
DermDocs
6 Listeners
EADV Podcast
2 Listeners
PeDRA Pearls
9 Listeners
The Dermalorian Podcast
6 Listeners
Cutaneous Miscellaneous: The Dermatology Residents Podcast
6 Listeners
Derms on Drugs
32 Listeners
The Spot Check
0 Listeners